Specializing in Technology Sales and Marketing
…………………………………………………………………………………………………………………………………..
Roxanne Engel, PhD
Roxanne Engel, Ph.D earned a Bachelor of Science degree from the University of Tampa where she majored in Biology and minored in Chemistry. She completed a research internship at James A. Haley Veterans’ Hospitaland then went on to earn a Doctorate of Philosophy in Biochemistry and Molecular Biology from the University of South Florida College of Medicine in Tampa. She completed her research and dissertation work at the H. Lee Moffitt Cancer Center and Research Institute where she discovered a novel mechanism of drug resistance in patients enrolled in the Center’s clinical trials for the treatment of multiple myeloma. She is the recipient of many distinctions and awards and notably, her graduate work earned her the recognition of “Most Outstanding Moffitt Affiliate”. Following graduation, Dr. Engel has been helping companies to bring their latest technologies to market and has worked for major medical and technology companies such as Quest Diagnostics and Metrohm. She completed a work fellowship in Herisau, Switzerland where she was trained in trace chemical analysis and advanced applications in ion chromatography. Dr. Engel has published technical papers, participated in symposia throughout the US and overseas and has appeared on national television as an invited subject matter expert in cancer carcinogens. She is an advisor for Northern Arizona Center for Emerging Technologies (NACET), a consultant for the Museum of Science and Industry (MOSI), a member of Innovaro’s Scientific Advisory Council, and a member of the Association of University Technology Managers (AUTM.)
Dr. Roxanne Engel serves as the company’s liaison for all medical and technical clients. She evaluates medical technologies, leads the process of translating technical information into market positions and consumer benefits, and coordinates research projects and product evaluations. Dr. Engel also focuses on helping emerging companies become established and roll-out their new technologies into the marketplace faster and more efficiently. Finally, in her role, she helps connect entrepreneurs and small companies with business leaders and university tech transfer offices to bring new technologies into the marketplace for general use.
Invited Speaking Engagements
For more information or to schedule a speaking engagement with Dr. Roxanne Engel, click here.
Environmental Protection Agency, Regional Headquarters, Dallas, TX. 19th Annual Quality Assurance Conference, “Trace Level Chlorate, Chlorite, and Bromate Determination along with other Anions by Ion Chromatography”.
Home Shopping Network (HSN), US Headquarters, St. Pete., FL. Invited Scientific Expert to lead a product-based panel discussion about green technologies on television.
University of South Florida, Tampa, FL. AMSGS Annual Meeting, “Non-traditional Careers in Science”.
Emory Dunwoody Medical Center, Atlanta, GA. Internal Medical Grand Rounds, “Genetic Susceptibility to Venous Thrombosis: Factor V Leiden and Factor II Prothrombin”.
University of Alabama Medical Center, Birmingham, AL. Internal Medicine Grand Rounds, “Hepatitis B and C Virus Epidemiology”.
Naval Hospital Beaufort, Beaufort, SC. OB/GYN Grand Rounds “Cystic Fibrosis: Genetic Testing and Infertility”.
Greenville Health System, Greenville, SC. 48th Annual Greenville Postgraduate Seminar, “Cytogenetic Chromosome Analysis”.
Pitt County Memorial Hospital, Greenville, NC. “Lipid Analysis”.
Cape Fear Hospital, Wilimington, NC. “Lyme Disease and Diagnostic Testing”.
Atlanta Medical Center, Atlanta, GA. “Prenatal Screening Guidelines and Methods”.
Atlanta Medical Center, Atlanta, GA. “Molecular Testing for Sexually Transmitted Diseases”.
Atlanta Medical Center, Atlanta, GA. “HIV Viral Load and Drug Resistance Testing”.
DeKalb Medical Center, Decatur, GA. Women’s Health Symposium, (1) “HPV and Cervical Cancer”, (2) HER2 Gene Amplification and Breast Cancer”, and (3) “Cardiovascular Risk”.
Redmond Regional Medical Center, Rome, GA. “Bladder Cancer Detection, Cytology, and FISH Testing”.
Tennessee State Society American Medical Technologists Meeting, Memphis, TN. “West Nile Virus Epidemiology, Diagnosis, and Clinical Management”.
Meeting of the American Society for Microbiology, Kalamazoo, MI. “The Future of Clinical Laboratory Medicine: A Visionary Look at Laboratory Testing in the Future”.
Quest Diagnostics Sales Academy, Nichols Institute, San Jan Capistrano, CA. “Leukemia and Lymphoma Analysis”.
Quest Diagnostics Sales Academy, Nichols Institute, San Juan Capistrano, CA. “How to Position Quest Diagnostic’s Oncology & Hematology Testing Services in the Marketplace”.
NYU Medical Center NY, NY. The 7th Conference of DNA Topoisomerase in Therapy, “A Practical Method for Identifying a Nuclear Export Signal in DNA Topoisomerase”.
Tulane University Medical Center, New Orleans, LA. American Association for Cancer Research, “The Nuclear-Cytoplasmic Shuttling of DNA Topoisomerase Correlates with Drug Sensitivity”.
Technical Papers
Engel, R. Ph.D. Dissertation, The Nuclear Export of DNA Topoisomerase IIa as a Mechanism of Drug Resistance in Human Myeloma Cells. University of South Florida, Dec. 2005
Engel, R., Valkov, NI., Gump, JL., Hazlehurst, L., Dalton, WS., Sullivan, DM. The Cytoplasmic Trafficking of DNA Topoisomerase IIa Correlates with Etoposide Resistance in Human Myeloma Cells. Experimental Cell Research, 2004, (295), 421-431.
Engel, R. and Turner, JG., Derderian, JA., Jove, R., Sullivan, DM. Human Topoisomerase IIa Nuclear Export is Mediated by Two CRM-1 Dependent Nuclear Export Signals. J. Cell Science 2004, (117), 3061-3071.
Engel, R., Valkov, NI., Sullivan, DM. Human DNA Topoisomerases: Molecular Targets in Cancer Therapy and Methods of Drug Resistance. Recent Res. Dev. Cell Biochem. 2003, (1), 207-215.
Valkov, NI., Gump, JL., Engel, R., Sullivan, DM Cell Density-Dependent VP-16 Sensitivity of Leukaemic Cells is Accompanied by the Translocation of Topoisomerase IIa from the Nucleus to the Cytoplasm. Br. J. Haem. 2000, (108), 331-343.
AW US6-0138-082009. The Determination of Trace Level Cations and Transition Metals by Conductivity. August, 2009.
AW US6-0133-062009. The Determination of Trace Level Copper in Power Plant Process Water by Ion Chromatography Using PCR and UV/VIS Detection. June, 2009.
AW US6-0135-042009. Determination of Halogens in Coal by Pyrolitic Combustion followed by Suppressed Conductivity Detection. April, 2009.
AW US6-012009. The Determination of Free and Total Glycerin in Biodiesel Blends using Anion Exchange Chromatography and Electrochemcial Detection. January, 2009.
sending...
Follow Us!